Market Size (2020)
2020
$1.00M
Vertical: HealthcareBase Year: 202013 Sections
Market Size (2020)
2020
$1.00M
Projected (2027)
2027
$8.00M
CAGR (2020–2027)
34.6%
34.6%Key Players
102+
This report covers COVID Testing Kit Market with forecasts from 2020 to 2027. 102 key companies are profiled.
The COVID Testing Kit Market market is projected to grow at a CAGR of 34.6% from 2020 to 2027.
Historical performance and future projections (2020–2030, USD Billion)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Size (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansAnalysis of COVID Testing Kit Market from 2020 to 2027. Covers Asia Pacific, South America, Europe, North America, Middle East and Africa.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2020
Historical Period
2020 – 2020
Forecast Period
2020 – 2027
Primary Interviews
150+
Historical data (2020–2020) and forecast period (2020–2027)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket estimates by geography (2027)
InsightAsia Pacific leads with $8.00M by 2027.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2020 | 2020 | 2027 | CAGR | SHARE |
|---|---|---|---|---|---|
| Asia Pacific | $1.00M | $5.00M | $8.00M | 34.6% | 20% |
| South America | $1.00M | $5.00M | $8.00M | 34.6% | 20% |
| Europe | $1.00M | $5.00M | $8.00M | 34.6% | 20% |
| North America | $1.00M | $5.00M | $8.00M | 34.6% | 20% |
| Middle East and Africa | $1.00M | $5.00M | $8.00M | 34.6% | 20% |
| Total | $5.00M | $25.00M | $40.00M | 34.6% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$80.00M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Product_RT-PCR | $40.00M | 34.6% | 89% |
| Product_Rapid Test Kit | $40.00M | 34.6% | 40% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on COVID Testing Kit Market covering market dynamics, competitive landscape, and strategic outlook.
The COVID Testing Kit Market market is projected to reach $8.00M by 2027, growing at 34.6% CAGR. The Product_RT-PCR segment holds the largest share.
The COVID Testing Kit Market market encompasses 5 key regions and 2 market segments, with the study period spanning 2020 to 2027. The market demonstrates a 34.6% compound annual growth rate, reflecting strong underlying demand fundamentals.
Among the identified segments, Product_RT-PCR leads with $40.00M by 2027, followed by Product_Rapid Test Kit at $40.00M. These segments collectively account for the largest share of total market revenue.
This report profiles 102 key companies operating in the COVID Testing Kit Market market, covering market positioning, product portfolios, and recent developments.
Leading players include Company 1, Company 2, and 97 others.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 102 companies operating in the COVID Testing Kit Market market, including revenue, employee count, and market positioning where available.
Showing 102 of 102 companies
Company 1
Company 1 — Healthcare
Company 2
Company 2 — Healthcare
Novavax, Inc.
Company Headquarters: Maryland, US Founded: 1987 Workforce: ~2,500 Company Working: Novavax, Inc. is a biotechnology company that commercializes and develops vaccines to prevent a wide range of infectious diseases. It designs recombinant nanoparticle vaccine technology that produces a strong immune response against a variety of pathogens. It is partnered with leading biopharma organizations, government agencies, research institutions, and foundations, namely the Coalition for Epidemic Preparedness Innovations (US), the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (US), the Serum Institute of India Pvt. Ltd. (India), SK Bioscience (South Korea), CPL Biological (India), and Takeda Pharmaceuticals (US). It has seven research and manufacturing facilities. It has presence in regions namely North America, Europe, and the Middle East and Africa
Ology Bioservices, Inc
Company Headquarters: Florida, US Founded: 1999 Workforce: ~800 Company Working: Ology Bioservices, Inc. is an integrated biopharmaceutical company that develops and manufactures biopharmaceuticals and medical devices. It specializes in cell therapy, gene therapy, viral vectors, antibodies, oncolytic viruses, biopharmaceutical manufacturing, and vaccines. It has collaboration and partnerships with recognized government agencies, namely the Department of Defense and Medical Countermeasures Advanced Development and Manufacturing, which support it in developing biodefense products. Moreover, it has decades of experience in developing, licensing, and manufacturing proteins, therapeutics, and vaccines. It develops products to offer both commercial customers and US governments. Furthermore, it is a wholly owned company of National Resilience, Inc. (US), and assisting Resilience through its services includes regulatory support from preclinical through licensure and cGMP manufacturing up to biosafety level 3 (BSL3).
Cleveland Biolabs, Inc
Company Headquarters: New York, US Founded: 2003 Workforce: ~150 Company Working: Cleveland Biolabs, Inc. is an innovative biopharmaceutical company developing products to address immune system diseases and serious medical needs. It is specialized in offering products such as radiation injury products, immune-oncology, and orphan drugs. It has nine product candidates in its pipeline that have been developing directly through itself or its wholly owned companies, namely Incuron, LLC (US) and Panacela Labs, Inc. (US). It has a proprietary platform, namely the Advanced Immunomodulating Multi-Receptor System (AIMS) platform, which is designed to restore immune homeostasis. Moreover, it has collaboration with government agencies which supports the advanced development and procurement of new medical countermeasures including drugs, vaccines, diagnostics, and medical supplies in order to protect public health from chemical, biological, radiological, and nuclear threats.
Fabentech Biotech
Company Headquarters: Lyon, US Founded: 2009 Workforce: ~25 Company Working: Fabentech Biotech is a pharmaceutical company that develops and manufactures polyclonal antibody treatments. Its platform is safe, tested, and fully validated on polyclonal antibody technology for fighting high-priority biological agents that could threaten public health. It has many local, national, and international partners, namely the National Institutes of Health (UK), US Army, World Health Organization, and the European Defense Fund, who are supporting its biodefense product development. This is the only company in Europe that is able to produce biodefense solutions while adhering to the most strict international norms
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
COVID Testing Kit Market